Gaucher panel

Taliglucerase alfa (Elelyso, supplied by Pfizer) is funded to treat Gaucher disease.

On this page

Special Authority process

Access to enzyme replacement therapy (ERT) for Gaucher disease is now handled through the standard Special Authority process. 

Schedule listing (includes link to special authority form)(external link)

Make a Special Authority application

Details of our decision to make this change